A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic Arthritis
Public ClinicalTrials.gov record NCT06624228. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Risankizumab-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic Arthritis
Study identification
- NCT ID
- NCT06624228
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- UCB Biopharma SRL
- Industry
- Enrollment
- 684 participants
Conditions and interventions
Conditions
Interventions
- Bimekizumab Drug
- Placebo Drug
- Risankizumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 20, 2024
- Primary completion
- Feb 5, 2026
- Completion
- May 25, 2026
- Last update posted
- Apr 12, 2026
2024 – 2026
United States locations
- U.S. sites
- 34
- U.S. states
- 16
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pa0016 50662 | Gilbert | Arizona | 85297 | — |
| Pa0016 50062 | Glendale | Arizona | 85306 | — |
| Pa0016 50058 | Phoenix | Arizona | 85032 | — |
| Pa0016 50131 | Sun City | Arizona | 85351 | — |
| Pa0016 50654 | Covina | California | 91722 | — |
| Pa0016 50663 | San Diego | California | 92128 | — |
| Pa0016 50672 | Santa Monica | California | 90404 | — |
| Pa0016 50630 | Clearwater | Florida | 33765 | — |
| Pa0016 50679 | Cutler Bay | Florida | 33189 | — |
| Pa0016 50685 | Fort Lauderdale | Florida | 33309 | — |
| Pa0016 50059 | Ormond Beach | Florida | 32174 | — |
| Pa0016 50324 | Plantation | Florida | 33324 | — |
| Pa0016 50678 | Zephyrhills | Florida | 33542 | — |
| Pa0016 50651 | Skokie | Illinois | 60076 | — |
| Pa0016 50650 | Willowbrook | Illinois | 60527 | — |
| Pa0016 50686 | Hagerstown | Maryland | 21740 | — |
| Pa0016 50665 | Lansing | Michigan | 48910 | — |
| Pa0016 50551 | Saint Clair Shores | Michigan | 48081 | — |
| Pa0016 50689 | Eagan | Minnesota | 55123 | — |
| Pa0016 50682 | Kansas City | Missouri | 64111 | — |
| Pa0016 50016 | St Louis | Missouri | 63141 | — |
| Pa0016 50653 | Albuquerque | New Mexico | 87102 | — |
| Pa0016 50666 | Brooklyn | New York | 11201 | — |
| Pa0016 50664 | Middletown | Ohio | 45044 | — |
| Pa0016 50680 | Vandalia | Ohio | 45377 | — |
| Pa0016 50652 | Duncansville | Pennsylvania | 16635 | — |
| Pa0016 50006 | Wyomissing | Pennsylvania | 19610 | — |
| Pa0016 50001 | Jackson | Tennessee | 38305 | — |
| Pa0016 50673 | Fort Worth | Texas | 76109 | — |
| Pa0016 50048 | Katy | Texas | 77449 | — |
| Pa0016 50657 | Lubbock | Texas | 79424 | — |
| Pa0016 50655 | Tomball | Texas | 77375 | — |
| Pa0016 50061 | Spokane Valley | Washington | 99216 | — |
| Pa0016 50674 | Glendale | Wisconsin | 53217 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 93 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06624228, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 12, 2026 · Synced May 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06624228 live on ClinicalTrials.gov.